OakChart

SELLAS Life Sciences Group Inc

SLSHealthcare·Biotechnology·USA·Small·NASD·Nov 13 • 6:58 AM ET

9.51+1.48 (18.43%)
2026-11-13 12:59 CET
Market cap
$1.92B
Revenue, TTM
0.00 USD m
Net income, TTM
-35.76 USD m
Free cash flow, TTM
-27.30 USD m
EPS diluted, TTM
-0.20
Price / earnings
-
Compare

Price

SLS against its 20, 50 and 200-day averages
Terms2050200BeatEarnings
Patternshover a marker to name it
RS 70R -0.05Price-0.08-0.065.0010.0015.0016.6M33.1MVolumeMay 26Jun 26Jul 26Aug 26Sep 26Oct 26Nov 26SLSclose 9.5120-day 9.8550-day 11.06200-day 8.799.5152w high 15.8852-week range, not 6 months

40.1% under the 52-week high of 15.88 on 30 Jun 2026. 52-week low 1.39 on 17 Nov 2025. Last 15 sessions, 74.2% high to low

Volume 0.30× normal · the line is the 50-bar volume average

Setup. RS line 70
CANSLIM 2 of 6 — fails: EPS Growth Qtr Over Qtr: High (>25%); EPS Growth This Year: High (>25%); 52-Week High/Low: 0-10% below High; Institutional Ownership: Over 50%
VCP 5 of 6 — fails: 52-Week High/Low: 0-10% below High
Minervini 3 of 4 — fails: 52-Week High/Low: 0-10% below High
Zanger 2 of 5 — fails: RSI (14): Not Oversold (>50); 20-Day High/Low: 0-5% below High; Relative Volume: Over 1.5
Leaders 3 of 5 — fails: 50-Day Simple Moving Average: Price above SMA50; 52-Week High/Low: 0-10% below High
Breakout 1 of 4 — fails: 52-Week High/Low: New High; Relative Volume: Over 2; 50-Day Simple Moving Average: Price above SMA50
Growth 1 of 4 — fails: EPS Growth Qtr Over Qtr: High (>25%); EPS Growth This Year: High (>25%); Return on Equity: Over +15%
Quality 2 of 5 — fails: Return on Equity: Over +15% — not on the tape: Net Profit Margin: High (>20%); P/E: Under 25
Value 1 of 4 — fails: P/B: Under 2; Return on Equity: Over +15% — not on the tape: P/E: Under 15
Income 0 of 4 — fails: Dividend Growth: Growing 2+ Years — not on the tape: Dividend Yield: Over 2%; Payout Ratio: Low (<20%); P/E: Under 25
Small Cap 3 of 4 — fails: Float: Under 100M
Accumulation 3 of 4 — fails: Institutional Transactions: Over +10%
Relative Strength 3 of 3

Profile

SLS
52-week range, 56% of the way up
1.3915.88

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

IndexRUT
Employees13
IPOMar 12, 2008
Beta2.72
ATR, 14d0.97
Rel volume0.30
Short float28.61%
Insider own1.11%
Inst own36.41%

Snapshot

6 groups

Valuation

IndexRUT
Market Cap$1.92B
Enterprise Value1.79B
Income-35.76M
Sales0.00M
Book / share0.65
Cash / share0.67
Dividend Est.-
Dividend TTM-
Dividend Ex-DateMar 24, 2011
Dividend Gr. 3/5Y- -
Payout-
Employees13
IPOMar 12, 2008

Ratios

Price / earnings-
Forward price / earnings-
Price / earnings / growth-
Price / sales-
Price / book14.68
Price / cash14.25
Price / free cash flow-
Value / cash profit-
Value / sales-
Quick Ratio14.92
Current Ratio14.92
Debt / equity0.00
Long-term debt / equity0.00
Options and shortYes / Yes

Earnings

Earnings / share-0.20
Earnings next year-0.10
Earnings next quarter-0.05
Earnings this year18.00%
Earnings next year53.66%
Earnings growth, 5 years-
Past earnings growth51.28% 34.92%
Past sales growth- -
Earnings vs last year35.38%
Sales vs last year-
Earnings vs last quarter20.45%
Sales vs last quarter-
EarningsNov 12 AMC
Surprise0.00% -

Ownership

Insiders own1.11%
Insider trades0.00%
Institutions own36.41%
Institution trades9.90%
Return on assets-37.13%
Return on equity-40.31%
Return on capital-27.13%
Gross Margin-
Operating margin-
Profit Margin-
20-day average-3.45%
50-day average-14.05%
200-day average8.18%

Technical

Shares out203.53M
Shares floating199.70M
Short / float28.61%
Short ratio8.38
Short interest57.13M
52-week high15.88 -40.1%
52-week low1.39 +584.2%
Volatility10.35% 10.79%
Average range0.97
Strength index47.31
Market sensitivity2.72
Relative volume0.30
Avg Volume6.81M
Volume103,699

Performance

Perf Week12.95%
Perf Month-16.14%
Perf Quarter-26.85%
Perf Half Y34.32%
Perf YTD152.25%
Perf Year551.37%
Perf 3Y980.68%
Perf 5Y32.45%
Perf 10Y-99.85%
Recommendation1.00
Target Price32.50
Prev Close8.03
Price9.51
Change %18.43%

Analyst ratings

latest 4 of 4
DateActionAnalystRating changeTargetImplied
Jul 21, 2021InitiatedCantor FitzgeraldOverweight$18+89.3%
Nov 01, 2018InitiatedOppenheimerOutperform
Apr 02, 2018InitiatedH.C. WainwrightBuy$11+15.7%
Mar 19, 2018UpgradeMaxim GroupHold → Buy$13+36.7%

Peers

Mkt cap
TickerCompanyMkt cap
SNDXSyndax Pharmaceuticals Inc868.77M
KURAKura Oncology Inc689.09M
DMRADamora Therapeutics Inc1.36B
RIGLRigel Pharmaceuticals860.34M
GERNGeron Corp625.42M
AAPGAscentage Pharma Group International ADR1.38B
ATNMActinium Pharmaceuticals Inc49.99M
ELTXElicio Therapeutics Inc44.16M
IMCRImmunocore Holdings plc ADR1.57B
CLLSCellectis ADR82.46M

Insider trading

1 filings
InsiderRelationshipDateTransactionCostSharesValueTotal heldForm
Kalin Katherine BachDirectorNov 19 '25Buy1.5963,400100,806104,400Nov 21 08:45 AM

Held by

AUM
TickerCompanyAUM
VTIVanguard Morningstar Total Stock Market ETFAUM: 696.31B
XBIState Street SPDR S&P Biotech ETFAUM: 10.59B
IWMiShares Russell 2000 Index FundAUM: 77.86B
VXFVanguard Extended Market Index ETFAUM: 30.79B
IWOiShares Russell 2000 Growth ETFAUM: 14.25B
VTWOVanguard Russell 2000 Index ETFAUM: 16.90B
SCHASchwab U.S. Small-Cap ETFAUM: 22.44B
VHTVanguard Health Care ETFAUM: 21.54B
IWCiShares Micro-Cap ETFAUM: 1.23B
VTWGVanguard Russell 2000 Growth Index ETFAUM: 1.43B

News

latest 14 of 100

Quarterly earnings

2026Q3 EPS -0.050 matched -0.050, from -0.060 a year earlier. Sales 0.00, from 0.00 a year earlier
EPS
0.0000-0.1072024Q4 EPS -0.060 against -0.10724Q42025Q1 EPS -0.070 against -0.10525Q12025Q2 EPS -0.070 against -0.07725Q22025Q3 EPS -0.060 against -0.07725Q32025Q4 EPS -0.050 against -0.06325Q42026Q1 EPS -0.050 against -0.06026Q12026Q2 EPS -0.050 against -0.04526Q22026Q3 EPS -0.050 against -0.05026Q3
Sales, USD millions
0.890-0.892024Q4 sales 0.00 against 0.0024Q42025Q1 sales 0.0025Q12025Q2 sales 0.00 against 0.0025Q22025Q3 sales 0.00 against 0.0025Q32025Q4 sales 0.0025Q42026Q1 sales 0.0026Q12026Q2 sales 0.0026Q22026Q3 sales 0.0026Q3

The outline behind the bar is the estimate. The filled bar is the print. Green beat it, red missed it.

PeriodReportedEPS adjustedEPS estEPS reportedSales act, USD mSales est, USD mSurpriseYear-ago quarterAnalystsNext session
2026Q3ended 2026-09-302026-11-12 16:30-0.050-0.050-0.0500.00-EPS 0.0% · sales -vs 2025Q3, year-ago quarter · EPS -16.7% · sales -2Open +16.94% vs SPY -0.14%. Close +18.43% vs SPY +0.30%
2026Q2ended 2026-06-302026-08-11 16:30-0.050-0.045-0.0510.00-EPS +11.1% · sales -vs 2025Q2, year-ago quarter · EPS -28.6% · sales -2Open +7.87% vs SPY +0.54%. Close +6.52% vs SPY +0.25%
2026Q1ended 2026-03-312026-05-12 16:30-0.050-0.060-0.0490.00-EPS -16.7% · sales -vs 2025Q1, year-ago quarter · EPS -28.6% · sales -2Open +20.98% vs SPY +0.04%. Close +25.10% vs SPY +0.56%
2025Q4ended 2025-12-312026-03-19 16:30-0.050-0.063-0.0500.00-EPS -21.0% · sales -vs 2024Q4, year-ago quarter · EPS -16.7% · sales -3Open +7.69% vs SPY -0.50%. Close -8.46% vs SPY -1.70%
2025Q3ended 2025-09-302025-11-12 16:30-0.060-0.077-0.0630.000.00EPS -21.8% · sales -vs 2024Q3, year-ago quarter · EPS -40.0% · sales -3 EPS · 1 salesOpen +0.67% vs SPY -0.42%. Close -2.01% vs SPY -1.66%
2025Q2ended 2025-06-302025-08-12 16:30-0.070-0.077-0.0670.000.00EPS -8.7% · sales -vs 2024Q2, year-ago quarter · EPS -46.2% · sales -3 EPS · 1 salesOpen +0.62% vs SPY +0.35%. Close -3.73% vs SPY +0.34%
2025Q1ended 2025-03-312025-05-13 16:30-0.070-0.105-0.0660.00-EPS -33.3% · sales -vs 2024Q1, year-ago quarter · EPS -66.7% · sales -2Open +4.26% vs SPY +0.17%. Close +7.09% vs SPY +0.13%
2024Q4ended 2024-12-312025-03-20 16:30-0.060-0.107-0.0910.000.00EPS -43.8% · sales -vs 2023Q4, year-ago quarter · EPS -73.9% · sales -3 EPS · 1 salesOpen -6.61% vs SPY -1.10%. Close -0.83% vs SPY -0.27%
2024Q3ended 2024-09-302024-11-13 16:30-0.100-0.127-0.1040.000.00EPS -21.1% · sales -vs 2023Q3, year-ago quarter · EPS -69.7% · sales -3 EPS · 1 salesOpen +0.79% vs SPY +0.02%. Close 0.00% vs SPY -0.64%
2024Q2ended 2024-06-302024-08-13 16:30-0.130-0.173-0.1300.000.00EPS -25.0% · sales -vs 2023Q2, year-ago quarter · EPS -58.1% · sales -3 EPS · 1 salesOpen 0.00% vs SPY +0.15%. Close +0.84% vs SPY +0.32%
2024Q1ended 2024-03-312024-05-14 16:30-0.210-0.160-0.2140.00-EPS +31.3% · sales -vs 2023Q1, year-ago quarter · EPS -55.3% · sales -1Open -1.46% vs SPY +0.48%. Close +7.30% vs SPY +1.24%
2023Q4ended 2023-12-312024-03-28 16:30-0.2300.087-0.253-13.00EPS -365.3% · sales -vs 2022Q4, year-ago quarter · EPS -30.3% · sales -3Open +1.98% vs SPY +0.15%. Close +5.94% vs SPY -0.17%
2023Q3ended 2023-09-302023-11-09 16:30-0.3300.018-0.3270.0013.00EPS -1985.7% · sales -100.0%vs 2022Q3, year-ago quarter · EPS -2.9% · sales -4 EPS · 3 sales-
2023Q2ended 2023-06-302023-08-10 16:30-0.310-0.355-0.3120.000.00EPS -12.7% · sales -vs 2022Q2, year-ago quarter · EPS -24.4% · sales -4 EPS · 2 sales-
2023Q1ended 2023-03-312023-05-11 16:30-0.470-0.290-0.4710.000.00EPS +62.1% · sales -vs 2022Q1, year-ago quarter · EPS -55.2% · sales -100.0%4 EPS · 2 sales-
2022Q4ended 2022-12-312023-03-16 16:30-0.330-0.320-0.4340.000.00EPS +3.1% · sales -vs 2021Q4, year-ago quarter · EPS +11.2% · sales -3 EPS · 2 sales-

Annual earnings

2025FY EPS -0.250 beat -0.260, from -0.500 a year earlier. Sales 0.00, from 0.00 a year earlier
EPS
0.0000-1602018FY EPS -157.5 against -16020182019FY EPS -10.920 against -9.70520192020FY EPS -2.110 against -1.83020202021FY EPS -1.333 against -1.33820212022FY EPS -2.130 against -2.09820222023FY EPS -1.340 against -1.00720232024FY EPS -0.500 against -0.53720242025FY EPS -0.250 against -0.2602025
Sales, USD millions
13.0002015FY sales 0.00 against 8.2920152016FY sales 0.00 against 0.0020162017FY sales 0.0020172021FY sales 7.60 against 5.0720212022FY sales 1.00 against 1.0020222023FY sales 0.00 against 13.0020232024FY sales 0.00 against 0.0020242025FY sales 0.002025

Reported years only. The outline behind the bar is the estimate. A later year with no print stays in the table.

earnings feed, not the snapshot. Not the statement ratio.

PeriodEPS adjustedEPS estEPS reportedSales act, USD mSales est, USD mP/E, earnings feed
2030FYestimate-2.340--630.294.06
2029FYestimate-1.230--357.597.73
2028FYestimate-0.035--122.04271.71
2027FYestimate--0.095--53.09-
2026FYestimate--0.205----
2025FY-0.250-0.260-0.2500.00--
2024FY-0.500-0.537-0.5050.000.00-
2023FY-1.340-1.007-1.3440.0013.00-
2022FY-2.130-2.098-2.1291.001.00-
2021FY-1.333-1.338-1.3377.605.07-
2020FY-2.110-1.830-2.110---
2019FY-10.920-9.705-10.924---
2018FY-157.5-160-157.72---
2017FY-522--15,6600.00--
2016FY-3,540-3,205-27,9900.000.00-
2015FY-12,300-8,940-11,4690.008.29-
2014FY-9,300-10,629-9,3009.328.53-
2013FY-25,500-12,300-25,5002.492.91-
2012FY-15,900-16,800-16,8000.000.00-
2011FY-9,600-12,300-9,6000.000.00-
2010FY-20,100-22,800-20,100-0.50-

Quarterly results

2026Q3 revenue 0.00, from 0.00 a year earlier
Revenue, USD millions
0.890-0.892024Q4 revenue 0.0024Q42025Q1 revenue 0.0025Q12025Q2 revenue 0.0025Q22025Q3 revenue 0.0025Q32025Q4 revenue 0.0025Q42026Q1 revenue 0.0026Q12026Q2 revenue 0.0026Q22026Q3 revenue 0.0026Q3

From the quarterly statement. Not an estimate.

Estimate revisions

Latest snapshot of each period and type. 2026Q4 E -0.05 per share.
PeriodTypeScaleDateMeanvs prior date
2026Q4Eper share2026-11-13-0.050.0%
2026Q4Rper share2026-11-13-0.050.0%
2026FYEper share2026-10-26-0.210.0%
2026Q3Eper share2026-10-26-0.050.0%
2026FYRper share2026-10-26-0.210.0%
2026Q3Rper share2026-10-26-0.050.0%
2026Q2Eper share2026-07-27-0.05-10.0%
2026Q2Rper share2026-07-27-0.05-10.0%
2026Q1Eper share2026-04-21-0.060.0%
2026Q1Rper share2026-04-21-0.060.0%
2025FYEper share2026-03-13-0.25-3.8%
2025Q4Eper share2026-03-13-0.05-21.0%
2025FYRper share2026-03-13-0.25-3.8%
2025Q4Rper share2026-03-13-0.05-21.0%
2025Q4Sper share2025-11-130.00-
2026FYSper share2025-11-1336.130.0%
2026Q1Sper share2025-11-130.00-
2026Q2Sper share2025-11-130.00-
2026Q3Sper share2025-11-130.00-
2026Q4Sper share2025-11-1336.130.0%
2025Q3Eper share2025-10-27-0.08-0.6%
2025Q3Rper share2025-10-27-0.08-0.6%
2025Q3Sper share2025-08-130.00-
2025Q2Eper share2025-07-28-0.080.0%
2025Q2Rper share2025-07-28-0.080.0%
2025FYSper share2025-06-160.00-
2025Q2Sper share2025-06-160.00-
2025Q1Eper share2025-03-21-0.110.0%
2025Q1Rper share2025-03-21-0.110.0%
2024FYEper share2025-03-20-0.50-6.8%
2024Q4Eper share2025-03-20-0.09-15.7%
2024FYRper share2025-03-20-0.50-6.8%
2024Q4Rper share2025-03-20-0.09-15.7%
2025Q1Sper share2025-03-200.00-
2024Q4Sper share2024-11-140.00-
2024Q3Eper share2024-10-28-0.130.0%
2024Q3Rper share2024-10-28-0.130.0%
2024Q3Sper share2024-08-140.00-
2024Q2Eper share2024-06-01-0.170.0%
2024Q2Rper share2024-06-01-0.170.0%
2024FYSper share2024-05-150.00-
2024Q2Sper share2024-05-150.00-
2024Q1Eper share2024-04-30-0.16-30.4%
2024Q1Rper share2024-04-30-0.16-30.4%
2023FYEper share2024-02-14-1.01-8.9%
2023FYRper share2024-02-14-1.01-8.9%
2024Q1Sper share2023-11-100.00-
2023FYSper share2023-07-0613.00-

Estimate history

Annual
Metric201720182019202020212022202320242025TTMMRQ
EPS per share-15659.922-157.722-10.924-2.11-1.337-2.129-1.344-0.505-0.246-0.1994-
Sales USD millions0002810000-
Shares million shares0051416213274153-204
Quarterly
MetricQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
EPS per share-0.104-0.091-0.066-0.067-0.063-0.05-0.049-0.051-0.05
Sales USD millions000000000
Shares million shares647491100125153181202204

Income statement, annual

USD millions, except where the row names a unit. The percent under a figure is against the same period a year earlier. TTM has no earlier TTM to compare with, and a ratio or a margin has no change.
MetricTTM2025FY12/31/20252024FY12/31/20242023FY12/31/20232022FY12/31/20222021FY12/31/20212020FY12/31/20202019FY12/31/20192018FY12/31/2018
Total Revenue0.000.000.000.00-100.0%1.00-86.8%7.60+300.0%1.900.000.00
Cost of Goods Sold Incl. D&A0.000.000.000.00-100.0%0.56-61.9%1.47+286.8%0.380.000.00
Gross Profit0.000.000.000.00-100.0%0.44-92.8%6.13+303.3%1.520.000.00
Selling, General and Administrative Excl. Other39.4528.27-10.3%31.51-16.8%37.87+16.9%32.39+25.9%25.72+39.0%18.50+7.5%17.21-20.1%21.54
Research and Development23.1616.02-16.1%19.10-20.4%24.01+18.5%20.27+29.4%15.67+68.9%9.28+27.3%7.29-16.9%8.77
Other Operating Expense0.000.000.000.000.000.000.000.000.00
Operating Income-39.45-28.27-31.51-37.87-31.95-19.59-16.98-17.21-21.54
Interest Expense0.000.000.000.000.000.000.00-0.27
Unusual Expense0.000.000.00-0.00-100.0%9.67+616.3%1.35-0.18-107.9%2.28-65.0%6.52
Net Income Before Taxes-35.76-26.86-30.88-37.34-41.30-20.94-16.77-19.37-29.05
Income Taxes0.000.000.000.000.00-0.24-0.02-0.08-1.38
Consolidated Net Income-35.76-26.86-30.88-37.34-41.30-20.70-16.76-19.54-28.16
Net Income From Continuing Operations-35.76-26.86-30.88-37.34-41.30-20.70-16.76-19.54-28.16
Net Income-35.76-26.86-30.88-37.34-41.30-20.70-16.84-27.95-41.25
EPS (Recurring) per share-0.18-0.25-0.50-1.34-1.78-1.28-2.13-10.30-140.28
EPS (Basic, Before Extraordinaries) per share-0.20-0.25-0.50-1.34-2.13-1.34-2.11-10.92-157.72
EPS (Diluted) per share-0.20-0.25-0.50-1.34-2.13-1.34-2.11-10.92-157.72
EBITDA-39.45-28.27-31.51-37.87-31.49-18.32-16.61-17.21-21.54
Non-Operating Income (Expense)3.681.41+123.8%0.63+18.9%0.53+65.6%0.32+3100.0%0.01-66.7%0.03-75.0%0.12-0.73
Other After Tax Adjustments0.000.000.000.000.000.000.00-0.24-0.49
Stock Option Compensation Expense4.021.96+25.6%1.56-25.4%2.09+20.8%1.73+71.3%1.01+140.5%0.420.0%0.42+35.5%0.31
Price To Sales Ratio ratio----45.7711.2624.39--
Gross Margin %----44.3080.6280.16--
Operating Margin %-----3,195.00-257.82-893.79--
Net Margin %-----4,130.10-272.36-886.05--
Shares Outstanding million shares203.53153.10+106.9%73.98+130.3%32.13+52.9%21.01+32.1%15.90+11.6%14.25+180.5%5.08+1054.5%0.44
Market Capitalization1,621.631,621.63+2115.3%73.20+115.4%33.99-30.0%48.59-44.7%87.85+28.3%68.45+226.7%20.95-22.7%27.09

Income statement, quarterly

USD millions, except where the row names a unit. The percent under a figure is against the same period a year earlier. TTM has no earlier TTM to compare with, and a ratio or a margin has no change.
Metric2026Q39/30/20262026Q26/30/20262026Q13/31/20262025Q412/31/20252025Q39/30/20252025Q26/30/20252025Q13/31/20252024Q412/31/2024
Total Revenue0.000.000.000.000.000.000.000.00
Cost of Goods Sold Incl. D&A0.000.000.000.000.000.000.000.00
Gross Profit0.000.000.000.000.000.000.000.00
Selling, General and Administrative Excl. Other11.31+59.7%10.63+54.7%9.25+52.6%8.26+19.4%7.08-3.4%6.87-9.8%6.06-37.1%6.92-15.4%
Research and Development7.03+66.6%6.27+62.0%5.13+59.8%4.73+6.5%4.22-3.2%3.87-25.4%3.21-37.2%4.44-12.9%
Other Operating Expense0.000.000.000.000.000.000.000.00
Operating Income-11.31-10.63-9.25-8.26-7.08-6.87-6.06-6.92
Interest Expense0.000.000.000.000.000.000.000.00
Unusual Expense0.000.000.000.000.000.000.000.00
Net Income Before Taxes-10.09-9.61-8.41-7.66-6.79-6.60-5.81-6.74
Income Taxes0.000.000.000.000.000.000.000.00
Consolidated Net Income-10.09-9.61-8.41-7.66-6.79-6.60-5.81-6.74
Net Income From Continuing Operations-10.09-9.61-8.41-7.66-6.79-6.60-5.81-6.74
Net Income-10.09-9.61-8.41-7.66-6.79-6.60-5.81-6.74
EPS (Recurring) per share-0.05-0.05-0.05-0.05-0.06-0.07-0.07-0.09
EPS (Basic, Before Extraordinaries) per share-0.05-0.05-0.05-0.05-0.06-0.07-0.07-0.09
EPS (Diluted) per share-0.05-0.05-0.05-0.05-0.06-0.07-0.07-0.09
EBITDA-11.31-10.63-9.25-8.26-7.08-6.87-6.06-6.92
Non-Operating Income (Expense)1.22+320.7%1.02+277.8%0.84+236.0%0.60+233.3%0.29+31.8%0.27+80.0%0.25+212.5%0.18+350.0%
Other After Tax Adjustments0.000.000.000.000.000.000.000.00
Stock Option Compensation Expense1.93+286.0%1.01+102.0%0.63+23.5%0.45+21.6%0.50+31.6%0.50+51.5%0.51+6.3%0.37-26.0%
Shares Outstanding million shares203.53+62.7%201.92+101.2%181.33+99.5%153.10+106.9%125.08+94.3%100.37+73.8%90.90+61.5%73.98+130.3%
Market Capitalization1,621.63+856.5%2,745.85+1156.6%759.64+674.3%537.01+633.6%169.53+110.8%218.51+217.9%98.11+76.1%73.20+115.4%

Balance sheet, annual

USD millions, except where the row names a unit. The percent under a figure is against the same period a year earlier. TTM has no earlier TTM to compare with, and a ratio or a margin has no change.
Metric2025FY12/31/20252024FY12/31/20242023FY12/31/20232022FY12/31/20222021FY12/31/20212020FY12/31/20202019FY12/31/20192018FY12/31/20182017FY12/31/2017
Cash & Short Term Investments71.89+413.9%13.99+431.9%2.63-84.7%17.23-19.7%21.45-39.4%35.40+379.7%7.38+35.4%5.45-57.3%12.75
Short Term Receivables0.000.000.000.000.000.00-100.0%0.310.000.00
Inventories0.000.000.000.000.000.000.000.000.00
Other Current Assets3.32+41.9%2.34+333.3%0.54+1.9%0.53-66.7%1.59+297.5%0.40-28.6%0.56+43.6%0.39+14.7%0.34
Total Current Assets75.21+360.6%16.33+415.1%3.17-82.2%17.76-22.9%23.04-35.6%35.80+334.5%8.24+41.1%5.84-55.4%13.09
Net Property, Plant & Equipment0.96+3.2%0.93+8.1%0.86-1.1%0.87+20.8%0.72-20.0%0.90+309.1%0.220.000.00
Total Investments and Advances0.000.000.000.000.000.000.000.000.00
Intangible Assets1.910.0%1.910.0%1.910.0%1.910.0%1.91-74.9%7.610.0%7.61-26.9%10.41-46.6%19.51
Deferred Tax Assets-0.20+11.1%0.180.0%0.18+20.0%0.15-87.0%1.15-1.43-
Other Assets0.26-3.7%0.27-3.6%0.28-30.0%0.40-32.2%0.59-66.1%1.74+222.2%0.54-18.2%0.66-29.0%0.93
Total Assets78.34+299.1%19.63+206.7%6.40-69.7%21.13-20.1%26.43-44.0%47.20+184.2%16.61-9.4%18.34-45.3%33.53
Short Term Debt Incl. Current Port. of LT Debt0.540.0%0.54+20.0%0.45+21.6%0.37+85.0%0.20+17.6%0.17-22.7%0.220.00-100.0%8.38
Accounts Payable2.95-15.7%3.50-37.9%5.64+67.9%3.36+57.0%2.14-54.1%4.66+19.5%3.90+4.0%3.75-67.9%11.69
Other Current Liabilities3.52-35.6%5.47-28.5%7.65-35.1%11.79+346.6%2.64-64.8%7.51+541.9%1.17-47.3%2.22-50.7%4.50
Total Current Liabilities7.02-26.2%9.51-30.7%13.73-11.5%15.52+211.6%4.98-59.6%12.34+133.3%5.29-11.4%5.97-75.7%24.57
Long Term Debt0.460.0%0.460.0%0.46-19.3%0.57-6.6%0.61-25.6%0.820.000.00-100.0%2.61
Provision for Risks Charges0.000.000.000.000.000.000.000.000.00
Deferred Tax Liabilities-0.20+11.1%0.180.0%0.18+20.0%0.15-89.2%1.39+434.6%0.26-85.4%1.78+6.6%1.67
Other Liabilities0.000.000.000.00-100.0%0.34-92.8%4.69-5.4%4.96-7.1%5.34+105.4%2.60
Total Liabilities7.47-26.5%10.17-29.3%14.38-11.7%16.28+167.8%6.08-68.4%19.23+82.8%10.52-19.7%13.10-58.4%31.46
Non-Equity Reserves0.000.000.000.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.000.000.000.00
Common Equity70.87+649.2%9.46-7.98-264.5%4.85-76.2%20.35-27.2%27.96+359.1%6.09+16.0%5.25+153.6%2.07
Total Shareholders Equity70.87+649.2%9.46-7.98-264.5%4.85-76.2%20.35-27.2%27.96+359.1%6.09+16.0%5.25+153.6%2.07
Accumulated Minority Interest0.000.000.000.000.000.000.000.000.00
Total Equity70.87+649.2%9.46-7.98-264.5%4.85-76.2%20.35-27.2%27.96+359.1%6.09+16.0%5.25+153.6%2.07
Total Liabilities & Stockholders Equity78.34+299.1%19.63+206.7%6.40-69.7%21.13-20.1%26.43-44.0%47.20+184.2%16.61-9.4%18.34-45.3%33.53
Book Value Per Share per share0.46+253.8%0.13-0.25-208.7%0.23-82.0%1.28-34.7%1.96+63.3%1.20-89.9%11.91-97.8%538.42
Tangible Book Value Per Share per share0.45+350.0%0.10-0.31-321.4%0.14-87.9%1.16-18.9%1.43-0.30-11.73-4,537.26
Full-Time Employees people13-13.3%15-6.3%16-5.9%17+54.5%11+57.1%7+40.0%5-37.5%8-27.3%11
Price to Book Ratio ratio11.784.21-7.863.864.322.963.595.170.75
Return on Assets %-54.84-237.23-271.27-173.70-56.23-52.53-111.78-108.59-49.18
Return on Equity %-66.88-4,147.88--327.81-85.70-98.41-344.59-769.95-159.01
Return on Invested Capital %-37.66-311.24--761.45-98.77-58.21-320.61-536.91-521.88
Quick Ratio ratio10.721.720.231.144.632.901.560.980.53
Current Ratio ratio10.721.720.231.144.632.901.560.980.53

Cash flow, annual

USD millions, except where the row names a unit. The percent under a figure is against the same period a year earlier. TTM has no earlier TTM to compare with, and a ratio or a margin has no change.
MetricTTM2025FY12/31/20252024FY12/31/20242023FY12/31/20232022FY12/31/20222021FY12/31/20212020FY12/31/20202019FY12/31/20192018FY12/31/2018
Net Income-35.76-26.86-30.88-37.34-41.30-20.70-16.68-19.29-27.67
Depreciation----0.46+170.6%0.17-55.3%0.38--
Other Funds (Non Cash)4.802.55+20.3%2.12-17.8%2.58-77.3%11.39+382.6%2.36+637.5%0.32-88.8%2.86-66.6%8.57
Funds from Operations-30.96-24.31-28.76-34.76-29.45-18.41-16.01-16.53-20.42
Extraordinary Item0.000.000.000.000.000.000.000.000.00
Changes in Working Capital3.66-4.08-6.65-298.5%3.35-40.6%5.64-7.62-236.3%5.59-1.11-10.01
Cash from Operating Activities-27.30-28.39-35.40-31.41-23.81-26.02-10.42-17.64-30.42
Capital Expenditures0.000.000.00-5.50-4.500.000.000.000.00
Net Assets From Acquisitions0.000.000.000.000.000.000.000.00-
Sale of Fixed Assets and Businesses0.000.000.000.000.000.000.000.000.00
Purchase or Sale of Investments0.000.000.000.000.000.000.000.000.00
Purchase of Investments0.000.000.000.000.000.000.000.000.00
Sale Or Maturity of Investments0.000.000.000.000.000.000.000.000.00
Other Uses0.000.000.000.000.000.000.000.000.00
Other Sources0.000.000.000.000.000.000.000.000.00
Cash from Investing Activities0.000.000.00-5.50-4.500.000.000.000.00
Cash Dividends Paid0.000.000.000.000.000.000.000.00-0.49
Change in Capital Stock118.2186.82+85.4%46.82+109.5%22.35-7.2%24.08+99.5%12.07-68.3%38.13+94.8%19.57-37.3%31.21
Repurchase of Common Pref Stock0.000.000.000.000.000.000.000.000.00
Sale of Common Pref Stock118.2186.82+85.4%46.82+109.5%22.35-7.2%24.08+99.5%12.07-68.3%38.13+94.8%19.57-37.3%31.21
Proceedsfrom Stock Options74.2474.20+60.4%46.26+107.2%22.33-7.3%24.08+167.3%9.01-69.6%29.60+85.3%15.97-48.8%31.21
Issuance or Reduction of Debt, Net0.000.000.000.000.000.000.000.00-7.60
Change in Long Term Debt0.000.000.000.000.000.000.000.00-7.60
Issuance of Long Term Debt0.000.000.000.000.000.000.000.000.00
Reduction of Long Term Debt0.000.000.000.000.000.000.000.00-7.60
Net Financing Active Other Cash Flow-0.53-0.53-0.06-0.030.000.00-100.0%0.310.000.00
Other Financing Activities Uses-0.53-0.53-0.06-0.030.000.000.000.000.00
Cash from Financing Activities117.6986.30+84.6%46.76+109.5%22.32-7.3%24.08+99.5%12.07-68.6%38.44+96.4%19.57-15.4%23.12
Net Change in Cash90.3957.91+409.8%11.36-14.60-4.23-13.95-149.8%28.02+1351.8%1.93-7.30
Free Cash Flow-27.30-28.39-35.40-36.91-28.31-26.02-10.42-17.64-
Preferred Dividends (Cash Flow)-0.000.000.000.000.00---
Deferred Taxes & Investment Tax Credit-0.000.000.000.00-0.24-0.02-0.10-1.32

Balance sheet, quarterly

USD millions, except where the row names a unit. The percent under a figure is against the same period a year earlier. TTM has no earlier TTM to compare with, and a ratio or a margin has no change.
Metric2026Q39/30/20262026Q26/30/20262026Q13/31/20262025Q412/31/20252025Q39/30/20252025Q26/30/20252025Q13/31/20252024Q412/31/2024
Cash & Short Term Investments134.81+203.5%138.44+445.0%107.20+276.1%71.89+413.9%44.42+110.2%25.40+174.6%28.50+53.9%13.99+431.9%
Short Term Receivables0.000.000.000.000.000.000.000.00
Inventories0.000.000.000.000.000.000.000.00
Other Current Assets3.76-18.8%4.06+0.2%3.97+14.1%3.32+41.9%4.63+59.7%4.05+32.4%3.48+16.4%2.34+333.3%
Total Current Assets138.57+182.5%142.50+383.9%111.17+247.7%75.21+360.6%49.05+104.0%29.45+139.4%31.97+48.7%16.33+415.1%
Net Property, Plant & Equipment0.58+3.6%0.71+4.4%0.84+3.7%0.96+3.2%0.56+9.8%0.68+7.9%0.81+8.0%0.93+8.1%
Total Investments and Advances0.000.000.000.000.000.000.000.00
Intangible Assets1.910.0%1.910.0%1.910.0%1.910.0%1.910.0%1.910.0%1.910.0%1.910.0%
Deferred Tax Assets-------0.20+11.1%
Other Assets0.030.0%0.25-3.8%0.260.0%0.26-3.7%0.03-25.0%0.26-3.7%0.26-3.7%0.27-3.6%
Total Assets141.09+173.7%145.38+350.1%114.18+226.6%78.34+299.1%51.55+94.5%32.30+113.6%34.96+43.1%19.63+206.7%
Short Term Debt Incl. Current Port. of LT Debt0.600.0%0.580.0%0.560.0%0.540.0%0.60+3.4%0.58+9.4%0.56+14.3%0.54+20.0%
Accounts Payable2.09-9.5%3.09-7.5%3.63-3.5%2.95-15.7%2.31-49.2%3.34-47.2%3.76-49.3%3.50-37.9%
Other Current Liabilities6.60+118.5%3.90+87.5%2.26-12.1%3.52-35.6%3.02-45.0%2.08-59.8%2.57-60.7%5.47-28.5%
Total Current Liabilities9.29+56.9%7.57+26.2%6.46-6.2%7.02-26.2%5.92-44.2%6.00-50.2%6.89-52.3%9.51-30.7%
Long Term Debt0.000.160.0%0.310.0%0.460.0%0.000.160.0%0.310.0%0.460.0%
Provision for Risks Charges0.000.000.000.000.000.000.000.00
Deferred Tax Liabilities-------0.20+11.1%
Other Liabilities0.000.000.000.000.000.000.000.00
Total Liabilities9.29+56.9%7.73+25.5%6.76-6.1%7.47-26.5%5.92-44.2%6.16-49.5%7.20-51.2%10.17-29.3%
Non-Equity Reserves0.000.000.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.000.000.00
Common Equity131.81+188.9%137.66+426.4%107.41+286.9%70.87+649.2%45.63+187.2%26.15+798.6%27.76+186.8%9.46
Total Shareholders Equity131.81+188.9%137.66+426.4%107.41+286.9%70.87+649.2%45.63+187.2%26.15+798.6%27.76+186.8%9.46
Accumulated Minority Interest0.000.000.000.000.000.000.000.00
Total Equity131.81+188.9%137.66+426.4%107.41+286.9%70.87+649.2%45.63+187.2%26.15+798.6%27.76+186.8%9.46
Total Liabilities & Stockholders Equity141.09+173.7%145.38+350.1%114.18+226.6%78.34+299.1%51.55+94.5%32.30+113.6%34.96+43.1%19.63+206.7%
Book Value Per Share per share0.65+80.6%0.68+161.5%0.59+90.3%0.46+253.8%0.36+44.0%0.26+420.0%0.31+82.4%0.13
Tangible Book Value Per Share per share0.64+82.9%0.67+179.2%0.58+107.1%0.45+350.0%0.35+59.1%0.24+1100.0%0.28+100.0%0.10
Full-Time Employees people---13-13.3%---15-6.3%
Price to Book Ratio ratio11.7824.929.1410.336.187.178.444.21
Return on Assets %-37.13-36.54-39.50-54.84-66.47-110.74-91.36-237.23
Return on Equity %-40.31-39.63-43.58-66.88-84.33-180.71-144.90-4,147.88
Return on Invested Capital %-7.66-6.97-7.80-10.74-14.88-25.09-20.71-67.90
Quick Ratio ratio14.9218.8317.2210.728.284.914.641.72
Current Ratio ratio14.9218.8317.2210.728.284.914.641.72

Cash flow, quarterly

USD millions, except where the row names a unit. The percent under a figure is against the same period a year earlier. TTM has no earlier TTM to compare with, and a ratio or a margin has no change.
Metric2026Q39/30/20262026Q26/30/20262026Q13/31/20262025Q412/31/20252025Q39/30/20252025Q26/30/20252025Q13/31/20252024Q412/31/2024
Net Income-10.09-9.61-8.41-7.66-6.79-6.60-5.81-6.74
Other Funds (Non Cash)2.08+220.0%1.17+80.0%0.95+46.2%0.60+15.4%0.65+25.0%0.65+38.3%0.65+6.6%0.52-16.1%
Funds from Operations-8.01-8.44-7.46-7.06-6.14-5.95-5.16-6.22
Extraordinary Item0.000.000.000.000.000.000.000.00
Changes in Working Capital2.070.85-1.392.14-0.93-1.38-3.91-0.94-134.9%
Cash from Operating Activities-5.94-7.59-8.85-4.92-7.07-7.33-9.07-7.15
Capital Expenditures0.000.000.000.000.000.000.000.00
Net Assets From Acquisitions0.000.000.000.000.000.000.000.00
Sale of Fixed Assets and Businesses0.000.000.000.000.000.000.000.00
Purchase or Sale of Investments0.000.000.000.000.000.000.000.00
Purchase of Investments0.000.000.000.000.000.000.000.00
Sale Or Maturity of Investments0.000.000.000.000.000.000.000.00
Other Uses0.000.000.000.000.000.000.000.00-100.0%
Other Sources0.000.000.000.000.000.000.000.00
Cash from Investing Activities0.000.000.000.000.000.000.000.00
Cash Dividends Paid0.000.000.000.000.000.000.000.00
Preferred Dividends (Cash Flow)0.000.000.000.000.000.000.000.00
Change in Capital Stock2.31-91.1%38.83+818.0%44.15+87.2%32.92+46928.6%26.09+32.5%4.23+931.7%23.58-11.5%0.07-98.0%
Repurchase of Common Pref Stock0.000.000.000.000.000.000.000.00
Sale of Common Pref Stock2.31-91.1%38.83+818.0%44.15+87.2%32.92+46928.6%26.09+32.5%4.23+931.7%23.58-11.5%0.07-98.0%
Proceedsfrom Stock Options0.08+33.3%0.000.07+40.0%74.09+60.5%0.06+20.0%0.000.050.0%46.16+1257.6%
Issuance or Reduction of Debt, Net0.000.000.000.000.000.000.000.00
Change in Long Term Debt0.000.000.000.000.000.000.000.00
Issuance of Long Term Debt0.000.000.000.000.000.000.000.00
Reduction of Long Term Debt0.000.000.000.000.000.000.000.00
Net Financing Active Other Cash Flow0.000.000.00-0.530.000.000.00-0.06
Other Financing Activities Uses0.000.000.00-0.530.000.000.00-0.06
Cash from Financing Activities2.31-91.1%38.83+818.0%44.15+87.2%32.39+323800.0%26.09+32.5%4.23+931.7%23.58-11.5%0.01-99.7%
Net Change in Cash-3.63-119.1%31.2535.30+143.3%27.4719.02+60.1%-3.1014.51-8.6%-7.14
Free Cash Flow-5.94-7.59-8.85-4.92-7.07-7.33-9.07-7.15

Revenue breakdown

Revenue split-

Short interest

shares short against float, oldest to newest
SettlementOf floatShares shortFloatAvg volume
2026-10-3028.61%57.1M199.7M6.65M
2026-10-1526.92%53.8M199.7M6.41M
2026-09-3027.61%55.1M199.7M7.20M
2026-09-1529.58%59.1M199.7M8.42M
2026-08-3129.01%57.9M199.7M8.40M
2026-08-1428.26%56.4M199.5M9.17M
2026-07-3129.91%55.0M183.8M9.58M
2026-07-1530.08%55.3M183.8M9.25M
2026-06-3034.45%63.3M183.8M8.40M
2026-06-1534.47%63.4M183.8M7.74M
2026-05-2932.94%61.0M185.2M7.82M
2026-05-1530.81%57.1M185.2M6.86M
2026-04-3032.23%57.1M177.3M6.29M
2026-04-1532.05%56.6M176.7M6.59M
2026-03-3130.29%53.5M176.7M8.59M
2026-03-1325.91%45.8M176.7M8.98M
2026-02-2735.05%49.1M140.2M8.62M
2026-02-1332.85%46.1M140.2M8.07M
2026-01-3029.49%41.3M140.2M7.93M
2026-01-1530.00%42.0M140.2M7.84M

Option chain

expiry 2026-11-13
TypeStrikeBidAskLastIVOpen intVolumeDeltaThetaVega
call1.005.407.907.5081.7324.000.000.990-0.1520.000
call2.004.406.706.5036.30426.000.000.984-0.1560.000
call3.003.405.905.6029.6337.000.000.977-0.1530.000
call3.502.806.404.4733.2524.000.000.973-0.1510.000
call4.002.254.804.1821.0824.001.000.968-0.1470.000
call4.501.704.604.0521.9655.000.000.963-0.1430.000
call5.002.553.703.3014.9891.000.000.956-0.1380.000
call5.501.053.600.0016.9040.000.000.947-0.1320.000
call6.000.952.852.6612.5292.000.000.936-0.1250.000
call6.500.202.451.8611.5074.000.000.920-0.1160.001
call7.000.751.651.447.4201380.000.814-0.2190.001
call7.500.501.000.804.76429.0052.000.691-0.2800.001
call8.000.300.550.503.5041,02496.000.544-0.3460.002
call8.500.050.300.253.1795052490.389-0.2910.001
call9.000.000.200.163.4292,9331,1400.270-0.2610.001
call9.500.050.200.154.2313732430.233-0.2980.001
call10.000.100.150.104.4631,9501490.178-0.2680.001
call10.500.050.100.054.5006352730.127-0.2160.001
call11.000.050.500.075.0271,69314.000.117-0.2280.001
call11.500.050.400.105.5155661630.109-0.2370.001
call12.000.050.100.055.97048593.000.103-0.2460.001
call12.500.000.750.056.3978361,1720.098-0.2540.001
call13.000.000.300.056.79852725.000.093-0.2610.001
call13.500.000.600.057.1762491.000.090-0.2670.001
call14.000.000.350.047.53880725.000.086-0.2730.001
call14.500.000.700.057.88059120.000.084-0.2790.001
call15.000.000.050.047.0091,70112.000.049-0.1640.000
call15.500.000.650.147.43738.000.000.048-0.1700.000
call16.000.000.050.017.7358675480.046-0.1730.000
call16.500.000.350.058.0031451000.045-0.1760.000
call17.000.000.750.058.25391.000.000.044-0.1770.000
call17.500.000.950.208.49873.000.000.043-0.1790.000
call18.000.000.750.118.7351190.000.042-0.1810.000
call18.500.003.400.008.9690.000.000.041-0.1830.000
call19.000.003.400.259.1871.000.000.041-0.1850.000
call19.500.000.950.259.4041.000.000.040-0.1870.000
call20.000.000.050.019.6052,0553000.039-0.1880.000
call20.500.000.950.009.8060.000.000.039-0.1900.000
call21.000.000.750.3010.00054.000.000.038-0.1910.000
call21.500.003.400.0010.1960.000.000.038-0.1930.000
call22.000.002.100.1510.3806.000.000.037-0.1940.000
call22.500.003.400.0010.5590.000.000.037-0.1950.000
call23.000.000.400.0510.7331270.000.036-0.1960.000
call24.000.003.400.0011.0680.000.000.035-0.1990.000
call25.000.000.550.1511.3863270.000.035-0.2010.000
put1.000.000.050.0317.3523.000.00-0.009-0.0710.000
put2.000.000.050.0311.64220.000.00-0.015-0.0730.000
put3.000.000.750.0812.1011030.00-0.023-0.1530.000
put3.500.000.750.0510.37810.000.00-0.027-0.1500.000
put4.000.000.550.038.8961291.00-0.032-0.1470.000
put4.500.000.750.057.5784160.00-0.037-0.1430.000
put5.000.000.050.058.1011,3980.00-0.077-0.2550.001
put5.500.000.050.066.90991.000.00-0.090-0.2440.001
put6.000.000.350.034.3023680.00-0.064-0.1240.000
put6.500.000.350.043.3482611.00-0.080-0.1150.001
put7.000.000.150.043.55228360.00-0.186-0.2190.001
put7.500.150.250.173.169148453-0.309-0.2790.001
put8.000.200.600.404.03538770.00-0.456-0.3450.002
put8.500.450.850.603.72595.0014.00-0.611-0.2900.001
put9.000.501.400.905.11223713.00-0.730-0.2600.001
put9.500.103.601.349.75043.000.00-0.767-0.2970.001
put10.001.402.452.017.1682258.00-0.822-0.2670.001
put10.501.853.202.309.69273.001.00-0.873-0.2150.001
put11.002.653.502.958.93716712.00-0.883-0.2260.001
put11.503.104.303.6511.73041.0024.00-0.891-0.2360.001
put12.003.304.503.8110.12422.004.00-0.897-0.2450.001
put12.502.456.404.7319.59037.000.00-0.902-0.2530.001
put13.004.106.305.4016.8505.000.00-0.907-0.2600.001
put13.504.507.005.1718.6891.000.00-0.910-0.2660.001
put14.005.307.105.4016.49116.000.00-0.914-0.2720.001
put14.504.408.404.7522.2660.000.00-0.916-0.2770.001
put15.004.908.906.7022.7081.000.00-0.951-0.1670.000
put15.505.409.307.1922.4741.000.00-0.952-0.1690.000
put16.005.909.808.5022.8751.000.00-0.954-0.1720.000
put16.506.4010.307.0023.2595.000.00-0.955-0.1740.000
put17.006.9010.800.0023.6270.000.00-0.956-0.1760.000
put17.507.4011.300.0023.9800.000.00-0.957-0.1780.000
put18.007.9011.800.0024.3190.000.00-0.958-0.1800.000
put18.508.4012.300.0024.6460.000.00-0.959-0.1810.000
put19.008.9012.800.0024.9600.000.00-0.959-0.1830.000
put19.509.4013.300.0025.2630.000.00-0.960-0.1850.000
put20.009.9013.800.0025.5570.000.00-0.961-0.1860.000
put20.5010.4014.3012.1125.8401.000.00-0.961-0.1880.000
put21.0010.9014.8012.6026.1141.000.00-0.962-0.1890.000
put21.5011.4015.500.0027.6960.000.00-0.962-0.1900.000
put22.0011.9015.800.0026.6370.000.00-0.963-0.1920.000
put22.5012.4016.300.0026.8870.000.00-0.963-0.1930.000
put23.0012.9017.000.0028.4490.000.00-0.964-0.1940.000
put24.0013.9017.800.0027.5960.000.00-0.965-0.1960.000
put25.0014.9019.000.0029.3570.000.00-0.965-0.1980.000

Latest SEC filings

30
FiledFormDescriptionPeriodLink
2026-11-128-KCurrent report2026-11-12SEC
2026-11-1210-QQuarterly report pursuant to Section 13 or 15(d)2026-09-30SEC
2026-11-10SCHEDULE 13GSEC
2026-10-27SCHEDULE 13G/ASEC
2026-08-118-KCurrent report2026-08-11SEC
2026-08-1110-QQuarterly report pursuant to Section 13 or 15(d)2026-06-30SEC
2026-08-07SCHEDULE 13GSEC
2026-07-31SCHEDULE 13GSEC
2026-07-278-KCurrent report2026-07-24SEC
2026-06-258-KCurrent report2026-06-24SEC
2026-06-188-KCurrent report2026-06-16SEC
2026-06-184Statement of changes in beneficial ownership of securities2026-06-16SEC
2026-06-16S-8Initial registration statement for securities to be offered to employees pursuant to employee benefit plansSEC
2026-06-028-KCurrent report2026-06-02SEC
2026-05-128-KCurrent report2026-05-12SEC
2026-05-1210-QQuarterly report pursuant to Section 13 or 15(d)2026-03-31SEC
2026-04-24SCHEDULE 13G/ASEC
2026-04-23ARSAnnual report to security holders. 2025-12-31SEC
2026-04-23DEFA14AProxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934SEC
2026-04-23DEF 14AProxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 19342026-06-16SEC
2026-03-27SCHEDULE 13G/ASEC
2026-03-20S-3ASRAutomatic shelf registration statement of securities of well-known seasoned issuersSEC
2026-03-198-KCurrent report2026-03-19SEC
2026-03-1910-KAnnual report pursuant to Section 13 or 15(d)2025-12-31SEC
2026-03-118-KCurrent report2026-03-11SEC
2026-02-17SCHEDULE 13G/ASEC
2026-01-30SCHEDULE 13G/ASEC
2026-01-094Statement of changes in beneficial ownership of securities2026-01-07SEC
2026-01-094Statement of changes in beneficial ownership of securities2026-01-07SEC
2026-01-094Statement of changes in beneficial ownership of securities2026-01-07SEC

Insider activity by month

MonthBoughtBuysSoldSells
2026-110000
2026-100000
2026-090000
2026-080000
2026-070000
2026-060000
2026-050000
2026-040000
2026-030000
2026-020000
2026-010000
2025-120000
2025-11100.81K100

Institutional holders

Manager% owned
BlackRock, Inc.8.10%
STATE STREET CORP5.14%
VANGUARD CAPITAL MANAGEMENT LLC4.42%
GEODE CAPITAL MANAGEMENT, LLC2.56%
Anson Funds Management LP2.42%
JONES FINANCIAL COMPANIES LLLP1.24%
VANGUARD PORTFOLIO MANAGEMENT LLC1.16%
SUSQUEHANNA INTERNATIONAL GROUP, LLP1.10%
NORTHERN TRUST CORP0.87%
UBS Group AG0.74%

Funds

Fund% owned
State Street(R) SPDR(R) S&P(R) Biotech ETF4.65%
iShares Russell 2000 ETF2.65%
VANGUARD EXTENDED MARKET INDEX FUND1.15%
Fidelity Small Cap Index Fund1.11%
iShares Russell 2000 Growth ETF0.94%
PGIM Jennison Natural Resources Fund0.55%
VANGUARD RUSSELL 2000 INDEX FUND0.54%
Fidelity Extended Market Index Fund0.45%
iShares Micro-Cap ETF0.34%
VANGUARD HEALTH CARE INDEX FUND0.27%

OakChart. SLS. Cached 15 minutes. Terms